# Prelude Therapeutics Inc > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/prelude-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 25 | | Claims under review | 1 | | Evidence records | 9 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:52:50.363049+00:00 | | Last reviewed | 2026-10-16T13:52:50.363049+00:00 | ## Identity - Legal name: Prelude Therapeutics Inc - Display name: Prelude Therapeutics Inc ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T13:52:50.363049+00:00 | | Completeness | 0.409 | | Record Quality | 0.843 | | Directors | 7 | | Committees | 5 | | Governance events | 15 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - David P. Bonita, M.D.: Director. Status: current. Independent: true. Since: 2016-01-01. claim_id=alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:5 - Krishna Vaddi, Ph.D.: Director. Status: current. Independent: false. Since: 2016-01-01. claim_id=alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:7 - Mardi Dier: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:8 - Martin Babler: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member). claim_id=alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:9 - Paul A. Friedman, M.D.: Director. Status: current. Independent: true. Since: 2016-01-01. claim_id=alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:10 - Victor Sandor, M.D.C.M.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:11 - Julian C. Baker: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. Committees: Compensation (member); Compensation; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:6 ## Committees - Audit (audit). Chair: Mardi Dier. Members: Mardi Dier (chair, current); Martin Babler (member, current). committee_id=alpha:committee:prelude-therapeutics-inc:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Mardi Dier (member, current). committee_id=alpha:committee:prelude-therapeutics-inc:audit-chair-compensation - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Julian C. Baker (member, current); Mardi Dier (member, current). committee_id=alpha:committee:prelude-therapeutics-inc:compensation - Compensation; Nominating and Governance · Chair (compensation). Chair: NOT_PUBLISHED. Members: Julian C. Baker (member, unknown). committee_id=alpha:committee:prelude-therapeutics-inc:compensation-nominating-and-governance-chair - Nominating and Governance (nominating_governance). Chair: Julian C. Baker. Members: Julian C. Baker (chair, current). committee_id=alpha:committee:prelude-therapeutics-inc:nominating-and-governance ## Executive leadership - Andrew P. Combs, Ph.D.: Chief Chemistry Officer. Status: current. claim_id=alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:12 - Bryant D. Lim, J.D.: Chief Legal Officer, Corporate Secretary, and Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:13 - Charles Q. Morris, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:14 - Krishna Vaddi, Ph.D.: Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:15 - Peggy A. Scherle, Ph.D.: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:16 - Sean P. Brusky, MBA: Chief Business Officer. Status: current. claim_id=alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:17 ## Governance events - EXECUTIVE_APPOINTED: Andrew P. Combs, Ph.D. executive of Prelude Therapeutics Inc, effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:ikmjzn1o98zyv - CFO_CHANGED: Bryant D. Lim, J.D. executive of Prelude Therapeutics Inc, effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:dtqva41u13b7i - EXECUTIVE_APPOINTED: Charles Q. Morris, M.D. executive of Prelude Therapeutics Inc, effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:uyeg77ag3t75 - CEO_CHANGED: Krishna Vaddi, Ph.D. executive of Prelude Therapeutics Inc, effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:1jcr3rj1v5qhpf - EXECUTIVE_APPOINTED: Peggy A. Scherle, Ph.D. executive of Prelude Therapeutics Inc, effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:1nqkfvh1gelyjl - EXECUTIVE_APPOINTED: Sean P. Brusky, MBA executive of Prelude Therapeutics Inc, effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:19djtrb1gi4xpp - DIRECTOR_APPOINTED: Martin Babler seat on Prelude Therapeutics Inc, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:1utfpph141zbvt - COMMITTEE_MEMBER_ADDED: Martin Babler member of Audit, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:6a4coick9l6y - DIRECTOR_APPOINTED: Mardi Dier seat on Prelude Therapeutics Inc, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:w859bretmqjh - DIRECTOR_APPOINTED: Victor Sandor, M.D.C.M. seat on Prelude Therapeutics Inc, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:d4nr1zl4fxy5 - COMMITTEE_CREATED: Audit · Chair; Compensation committee of Prelude Therapeutics Inc, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:16fmpth1xznsvd - COMMITTEE_MEMBER_ADDED: Mardi Dier member of Audit · Chair; Compensation, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:1j4ytqntxab6l - DIRECTOR_APPOINTED: David P. Bonita, M.D. seat on Prelude Therapeutics Inc, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:1kq2rzfmyag9h - DIRECTOR_APPOINTED: Krishna Vaddi, Ph.D. seat on Prelude Therapeutics Inc, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:y6i3l514rkt27 - DIRECTOR_APPOINTED: Paul A. Friedman, M.D. seat on Prelude Therapeutics Inc, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T13:52:50.363049+00:00. event_id=alpha:event:transition:ssydil1ihlp6d ## Scoped resources - `alpha://company/prelude-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record - `alpha://company/prelude-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=identity - `alpha://company/prelude-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/prelude-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=board - `alpha://company/prelude-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=committees - `alpha://company/prelude-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=leadership - `alpha://company/prelude-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=ownership - `alpha://company/prelude-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=financials - `alpha://company/prelude-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/prelude-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=compensation - `alpha://company/prelude-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=governance - `alpha://company/prelude-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/prelude-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=audit - `alpha://company/prelude-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=legal - `alpha://company/prelude-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=risk - `alpha://company/prelude-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=cyber - `alpha://company/prelude-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/prelude-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=agents - `alpha://company/prelude-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/prelude-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=events - `alpha://company/prelude-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=relationships - `alpha://company/prelude-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=assessments - `alpha://company/prelude-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:mardi-c-dier","name":"Mardi Dier"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:martin-babler","name":"Martin Babler"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:julian-c-baker","name":"Julian C. Baker"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:mardi-c-dier","name":"Mardi Dier"},"source_id":"board_seats"}` - Claim alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:julian-c-baker","name":"Julian C. Baker"},"source_id":"board_seats"}` ## Leadership - David P. Bonita, M.D.: Director. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:5. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3f5c4c4e10ca3850352c81863e45108e75411b25d5191fde43ca32a250b42f60. - Julian C. Baker: Director, Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3f5c4c4e10ca3850352c81863e45108e75411b25d5191fde43ca32a250b42f60. - Krishna Vaddi, Ph.D.: Director. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:7. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3f5c4c4e10ca3850352c81863e45108e75411b25d5191fde43ca32a250b42f60. - Mardi Dier: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:8. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3f5c4c4e10ca3850352c81863e45108e75411b25d5191fde43ca32a250b42f60. - Martin Babler: Director, Audit. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3f5c4c4e10ca3850352c81863e45108e75411b25d5191fde43ca32a250b42f60. - Paul A. Friedman, M.D.: Director. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:10. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3f5c4c4e10ca3850352c81863e45108e75411b25d5191fde43ca32a250b42f60. - Victor Sandor, M.D.C.M.: Director. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:11. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3f5c4c4e10ca3850352c81863e45108e75411b25d5191fde43ca32a250b42f60. - Andrew P. Combs, Ph.D.: Chief Chemistry Officer. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:12. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4895bb0e9a6c79d01bd4893671bb47ae2ad329a79097e842b563decb35a0d91e. - Bryant D. Lim, J.D.: Chief Legal Officer, Corporate Secretary, and Chief Financial Officer. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:13. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7571badb040e02245418faca9e715d9af88aa9deb09635bfab42e6dc616774bd. - Charles Q. Morris, M.D.: Chief Medical Officer. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:14. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bf2cf1d8fd8c2ab6f69c5f0beb70c126b5a8473741b8373314454cc6c77e826b. - Krishna Vaddi, Ph.D.: Chief Executive Officer and Director. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:15. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fa9e3c5437d73edbd0010a254717774b12391b8275eb495fac432e7ca215645f. - Peggy A. Scherle, Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:16. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f4c994416c094649f8147e61bd7dc2ef7ba4f9dd2527d187c7fb3d9614ea025d. - Sean P. Brusky, MBA: Chief Business Officer. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:leadership_role:17. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a5f6c6d31ed8dbd7b386d161c44e4cf77322094c10f293c329edd1dd2ca5e637. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Mardi Dier; Members Mardi Dier (Chair); Martin Babler. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8a70bd32899c4605d3055ddd667a3912302f0f2fbcf80a2c016cf48d4983ae5a. - Compensation: Chair not stated; Members Julian C. Baker; Mardi Dier. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8a70bd32899c4605d3055ddd667a3912302f0f2fbcf80a2c016cf48d4983ae5a. - Nominating and Governance: Chair Julian C. Baker; Members Julian C. Baker (Chair). Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8a70bd32899c4605d3055ddd667a3912302f0f2fbcf80a2c016cf48d4983ae5a. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Prelude Therapeutics Inc. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c6953a7db87b8df836eda2353e82a4af7178604fe243333393d6e7e44cdfcf09. ## Entity Status - Public listing published. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c6953a7db87b8df836eda2353e82a4af7178604fe243333393d6e7e44cdfcf09. ## Published Fact - US. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c6953a7db87b8df836eda2353e82a4af7178604fe243333393d6e7e44cdfcf09. ## Committee Appointment - Mardi Dier: chair, Audit. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8a70bd32899c4605d3055ddd667a3912302f0f2fbcf80a2c016cf48d4983ae5a. - Martin Babler: member, Audit. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8a70bd32899c4605d3055ddd667a3912302f0f2fbcf80a2c016cf48d4983ae5a. - Julian C. Baker: member, Compensation. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8a70bd32899c4605d3055ddd667a3912302f0f2fbcf80a2c016cf48d4983ae5a. - Mardi Dier: member, Compensation. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8a70bd32899c4605d3055ddd667a3912302f0f2fbcf80a2c016cf48d4983ae5a. - Julian C. Baker: chair, Nominating and Governance. Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8a70bd32899c4605d3055ddd667a3912302f0f2fbcf80a2c016cf48d4983ae5a. ## Security Listing - PRLD (NASDAQ). Claim: alpha:claim:company:ed6dd5a8-73ec-4cb4-8532-7ab80167abeb:security_listing:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c6953a7db87b8df836eda2353e82a4af7178604fe243333393d6e7e44cdfcf09. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:c6953a7db87b8df836eda2353e82a4af7178604fe243333393d6e7e44cdfcf09: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/prelude-therapeutics-inc). - alpha:projection-evidence:document:3f5c4c4e10ca3850352c81863e45108e75411b25d5191fde43ca32a250b42f60: [Prelude Therapeutics Inc DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1678660/000095017025059549/prld-20250429.htm). - alpha:projection-evidence:document:4895bb0e9a6c79d01bd4893671bb47ae2ad329a79097e842b563decb35a0d91e: [PRLD DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1678660/000119312526191532/prld-20260429.htm). - alpha:projection-evidence:document:7571badb040e02245418faca9e715d9af88aa9deb09635bfab42e6dc616774bd: [PRLD DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1678660/000119312526191532/prld-20260429.htm). - alpha:projection-evidence:document:bf2cf1d8fd8c2ab6f69c5f0beb70c126b5a8473741b8373314454cc6c77e826b: [PRLD DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1678660/000119312526191532/prld-20260429.htm). - alpha:projection-evidence:document:fa9e3c5437d73edbd0010a254717774b12391b8275eb495fac432e7ca215645f: [PRLD DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1678660/000119312526191532/prld-20260429.htm). - alpha:projection-evidence:document:f4c994416c094649f8147e61bd7dc2ef7ba4f9dd2527d187c7fb3d9614ea025d: [PRLD DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1678660/000119312526191532/prld-20260429.htm). - alpha:projection-evidence:document:a5f6c6d31ed8dbd7b386d161c44e4cf77322094c10f293c329edd1dd2ca5e637: [PRLD DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1678660/000119312526191532/prld-20260429.htm). - alpha:projection-evidence:8a70bd32899c4605d3055ddd667a3912302f0f2fbcf80a2c016cf48d4983ae5a: [Audit](https://www.sec.gov/Archives/edgar/data/1678660/000095017025059549/prld-20250429.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/prelude-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/prelude-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/prelude-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/prelude-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-16T17:07:37.521964+00:00; recorded 2026-10-16T17:07:37.521964+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.